Niflumic acid
Code | Size | Price |
---|
TAR-T0693-50mg | 50mg | £106.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0693-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0693-100mg | 100mg | £114.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0693-200mg | 200mg | £131.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0693-500mg | 500mg | £166.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Niflumic acid is a Ca2+-activated Cl- channel blocker and an analgesic and anti-inflammatory agent used in the therapy of rheumatoid arthritis.
CAS:
4394-00-7
Formula:
C13H9F3N2O2
Molecular Weight:
282.222
Pathway:
Immunology/Inflammation; Metabolism; ; Neuroscience; Membrane transporter/Ion channel
Purity:
0.9979
SMILES:
OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
Target:
Phospholipase; Chloride channel; COX; Monocarboxylate transporter; UGT
References
1. White MM, et al. Mol Pharmacol, 1990, 37(5), 720-724.
2. Goelein H, et al. FEBS Lett, 1990, 268(1), 79-82.
3. Ottolia M, et al. Biophys J, 1994, 67(6), 2272-2279.
4. Hogg RC, et al. Br J Pharmacol, 1994, 112(3), 977-984.
5. Kuang Y, Chai Y, Xu L, et al. Glabrone as a specific UGT1A9 probe substrate and its application in discovering the inhibitor glycycoumarin[J]. European Journal of Pharmaceutical Sciences. 2021: 105786.